CCL3/MIP-1α Antibody (Rabbit mAb) [C14E20]

Catalog No.: F9739

    Application: Reactivity:
    • Lane 1: THP-1, Lane 2: THP-1 (PMA, LPS, Brefeldin A treated)
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:20%
    転写条件(ウェット): 200 mA, 60 min,Recommended to use 0.22 μm PVDF 膜の使用をお勧めします。

    使用情報

    Dilution
    1:1000
    Application
    WB
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    10 kDa
    ポジティブコントロール NK-92 cells; U266B1 cells
    ネガティブコントロール HeLa cells; HT-29 cells; MCF7 cells; NCI-H929 ccells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 20%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.22 µm PVDF membrane is recommended )Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    CCL3/MIP-1α Antibody (Rabbit mAb) [C14E20] detects endogenous levels of total CCL3/MIP-1α protein.
    タンパク質の局在
    細胞外環境
    Uniprot ID
    P10147
    Clone
    C14E20
    Synonym(s)
    C-C motif chemokine 3, C-C motif chemokine ligand 3, CCL3, G0/G1 switch regulatory protein 19-1, G0S19-1, LD78-alpha(4-69), LD78ALPHA, MIP-1-alpha, MIP-1-alpha(4-69), MIP1A, PAT 464.1, SCYA3, SIS-beta
    Background
    CCL3, also known as macrophage inflammatory protein‑1α (MIP‑1α), is a CC chemokine produced by activated macrophages, monocytes, T cells, NK cells, and other leukocytes, and functions as a potent mediator of inflammatory cell recruitment, hematopoietic regulation, and tissue remodeling through high-affinity interactions with the chemokine receptors CCR1 and CCR5 on responsive target cells. The mature secreted chemokine adopts the characteristic CC chemokine fold with an N‑terminal region that contains the CC motif required for receptor activation and a surface enriched in basic residues that supports binding to glycosaminoglycans, which concentrates CCL3 on endothelial and stromal surfaces and establishes haptotactic gradients that guide leukocyte chemotaxis. Engagement of CCR1 or CCR5 by CCL3 activates Gi-coupled signaling, leading to inhibition of adenylyl cyclase, mobilization of intracellular Ca²⁺, and activation of downstream ERK1/2, JNK, and p38 MAPK pathways, which drive integrin activation, cytoskeletal rearrangement, and actin polymerization required for firm adhesion and directed migration across endothelium toward inflammatory foci. These signaling events also induce transcription and secretion of additional proinflammatory mediators, including TNF‑α and IL‑6, and can upregulate expression of CCR1 and CCR5 themselves, creating feed-forward loops that amplify local inflammatory responses and sustain accumulation and activation of monocytes, neutrophils, T cells, and NK cells within inflamed tissues. At the level of hematopoiesis, CCL3 acts directly on hematopoietic stem and progenitor cells to inhibit stem cell proliferation while permitting or enhancing proliferation of more mature progenitor subsets, a property that underpins its designation as a stem cell inhibitor and links CCL3 signaling to the control of stem cell quiescence and niche homeostasis in bone marrow. In the context of hematologic malignancy, particularly acute and chronic leukemias and multiple myeloma, elevated CCL3 expression in the marrow microenvironment correlates with disease burden and contributes to leukemogenesis by maintaining an inflammatory milieu, modulating stem/progenitor dynamics, and regulating osteoclast differentiation and activity, which promotes bone resorption and supports tumor cell growth. Within bone, CCL3 drives osteoclastogenesis via CCR1/CCR5-dependent pathways and simultaneously suppresses osteoblast function through ERK-mediated downregulation of osteogenic transcription factors such as osterix, leading to decreased osteocalcin production, impaired mineralization, and uncoupling of bone resorption from bone formation, a mechanism that underlies myeloma-induced osteolytic disease. The chemokine also participates in neuroimmune regulation, where elevated CCL3 in the central nervous system impairs synaptic transmission and hippocampal plasticity and modifies memory performance, reflecting direct effects on neuronal and glial signaling in addition to its classical roles in leukocyte recruitment.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください